Boston Scientific

Company BSX

Last mentioned: 4d ago

Stories mentioning Boston Scientific 2

pharma Bullish

Biotech Sector Pivots: Codexis, Elutia, and Biote Signal Strategic Shifts

Q4 2025 earnings for specialized biotech firms reveal a sector-wide shift toward high-margin manufacturing and strategic divestitures. While Codexis capitalizes on its Merck partnership and ECOsynthesis platform, Elutia has cleared its debt through an $88 million divestiture to Boston Scientific.

9 sources
pharma Bearish

Australia Slashes Subsidies for Spinal Implants Amid Safety Concerns

The Australian government is significantly reducing subsidies for high-cost spinal cord stimulators following reports of severe patient injuries and a lack of clinical efficacy. This regulatory shift targets a multi-million dollar sector of the medical device market, forcing manufacturers to justify the high price tags of chronic pain technologies.

3 sources